Previous researches have also indicated the intimate correlation between dysregulated expression of NFKBIZ and liver diseases such as acute hepatitis, nonalcoholic fatty liver disease and HBV- related HCC [12, 13]. This evidence concerns the gene NFKBIZ and metabolic dysfunction-associated steatotic liver disease.